CIK 0001719714 · Non-accelerated filer<br>Smaller reporting company
Mereo BioPharma Group plc
Sign in to watch- Ticker
- MREO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 4403330237300
- Business address
- ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-12 | Hughes-Wilson Alexandra See Remarks | Sale | −40,029 | $4.47 | $179K | 150,787 |
| 2024-09-11 | Sermon Charles General Counsel | Option exercise | +65,600 | 249,987 | ||
| 2024-09-11 | Sermon Charles General Counsel | Option exercise · Performance Based Restricted Stock Unit | −65,600 | 0 | ||
| 2024-09-11 | Fox Christine Ann Chief Financial Officer | Option exercise | +60,000 | 117,571 | ||
| 2024-09-11 | Fox Christine Ann Chief Financial Officer | Option exercise · Performance Based Restricted Stock Unit | −60,000 | 0 | ||
| 2024-09-11 | Lewicki John A. Chief Scientific Officer | Option exercise | +46,000 | 94,779 | ||
| 2024-09-11 | Lewicki John A. Chief Scientific Officer | Option exercise · Performance Based Restricted Stock Unit | −46,000 | 0 | ||
| 2024-09-11 | Scots-Knight Denise Chief Executive Officer | Option exercise | +188,060 | 897,578 | ||
| 2024-09-11 | Scots-Knight Denise Chief Executive Officer | Option exercise · Performance Based Restricted Stock Unit | −188,060 | 0 | ||
| 2024-09-11 | Hughes-Wilson Alexandra See Remarks | Option exercise | +40,000 | 74,548 | ||
| 2024-09-11 | Hughes-Wilson Alexandra See Remarks | Option exercise | +93,333 | $1.40 | $131K | 167,881 |
| 2024-09-11 | Hughes-Wilson Alexandra See Remarks | Option exercise | +75,000 | $1.01 | $76K | 242,881 |
| 2024-09-11 | Hughes-Wilson Alexandra See Remarks | Option exercise · Performance Based Restricted Stock Unit | −40,000 | 0 | ||
| 2024-09-11 | Hughes-Wilson Alexandra See Remarks | Option exercise · Share Options (Right to buy) | −93,333 | $1.40 | $131K | 0 |
| 2024-09-11 | Hughes-Wilson Alexandra See Remarks | Option exercise · Share Options (Right to buy) | −75,000 | $1.01 | $76K | 0 |
| 2024-08-22 | PAKIANATHAN DEEPIKA Director | Option exercise | +1,825 | $3.00 | $5K | 1,825 |
| 2024-08-22 | PAKIANATHAN DEEPIKA Director | Option exercise | +6,492 | $1.84 | $12K | 8,317 |
| 2024-08-22 | PAKIANATHAN DEEPIKA Director | Option exercise | +12,418 | $2.72 | $34K | 20,735 |
| 2024-08-22 | PAKIANATHAN DEEPIKA Director | Option exercise | +38,953 | $1.31 | $51K | 59,688 |
| 2024-08-22 | PAKIANATHAN DEEPIKA Director | Option exercise | +43,485 | $0.94 | $41K | 103,173 |
Page 4 of 7 · 139 trades